FTF PHARMA PRIVATE LIMITED
Patent Applications and Registrations
Patent applications and USPTO patent grants for FTF PHARMA PRIVATE LIMITED.The latest application filed is for "pharmaceutical formulations comprising diclofenac".
- FTF PHARMA PRIVATE LIMITED - Ahmedabad IN
- FTF PHARMA PRIVATE LTD - AHMEDABAD IN
- FTF Pharma Private Limited - Satellite IN
- FTF PHARMA PRIVATE LIMITED - Sanand IN
- FTF PHARMA PRIVATE LIMITED - Sanand, Ahmedabad IN
- FTF PHARMA PRIVATE LIMITED - Ahmedabad, Gujarat IN
- FTF Pharma Private Limited - Ahmedabad, GJ IN
- FTF Pharma Private Limited - Taluka: Sanand Dist.: Ahmedabad IN
- FTF PHARMA PRIVATE LIMITED - Sanand dist.: Gujarat, Ahmedabad IN
- FTF Pharma Private Limited - Satellite, Ahmedabad IN
| Patent | Date |
|---|---|
| Pharmaceutical Formulations Comprising Diclofenac App 20220280463 - MANDAL; Jayanta Kumar ; et al. | 2022-09-08 |
| Liquid Dosage Forms Of Imatinib App 20220160709 - MEHTA; Sandip ; et al. | 2022-05-26 |
| Stable Parenteral Dosage Form Of Pyrazolone Derivative App 20220105000 - MANDAL; Jayanta Kumar ; et al. | 2022-04-07 |
| Pharmaceutical Solution For Oral Dosage App 20220023288 - MEHTA; SANDIP ; et al. | 2022-01-27 |
| Pharmaceutical composition of pemetrexed Grant 11,147,817 - Mandal , et al. October 19, 2 | 2021-10-19 |
| Pharmaceutical composition of oral suspension of anti-neoplastic alkylating agents Grant 11,147,810 - Mehta , et al. October 19, 2 | 2021-10-19 |
| Pharmaceutical Suspension For Oral Dosage App 20210308044 - MEHTA; SANDIP ; et al. | 2021-10-07 |
| Liquid Compositions Of Aprepitant App 20210213024 - NAGAR; SWATI ; et al. | 2021-07-15 |
| Pharmaceutical Composition Of Pemetrexed App 20210100804 - MANDAL; Jayanta Kumar ; et al. | 2021-04-08 |
| Liquid Parenteral Compositions Of Levothyroxine App 20210059967 - PARIKH; Kinjal ; et al. | 2021-03-04 |
| Liquid Oral Formulations For Pde V Inhibitors App 20210052591 - PANDYA; Jinal ; et al. | 2021-02-25 |
| Liquid Dosage Forms Of Cinacalcet Or Salt Thereof App 20210030671 - NAGAR; Swati ; et al. | 2021-02-04 |
| Pharmaceutical Composition Of Oral Suspension Of Immunosuppressive Agents App 20200246261 - Kind Code | 2020-08-06 |
| Liquid Dosage Forms Of Imatinib App 20200206223 - MEHTA; Sandip ; et al. | 2020-07-02 |
| Pre-mixed, Ready To Use Vancomycin Compositions App 20200188478 - CHANDARANA; Dhaval ; et al. | 2020-06-18 |
| Pharmaceutical Composition Of Oral Suspension Of Anti-neoplastic Alkylating Agents App 20200069678 - MEHTA; Sandip ; et al. | 2020-03-05 |
| Method For Preparation Of Liquid Oral Composition Of L-thyroxin App 20200046664 - PATEL; Vijay ; et al. | 2020-02-13 |
| Pharmaceutical Composition Of Oral Solution Of Muscarinic Antagonist App 20200022910 - MEHTA; Sandip ; et al. | 2020-01-23 |
| Composition Comprising Bortezomib App 20190290718 - Mandal; Jayanta Kumar ; et al. | 2019-09-26 |
| Pharmaceutical Composition Comprising An Androgen Receptor Inhibitor App 20190209469 - PATEL; Nileshkumar Bhikhabhai ; et al. | 2019-07-11 |
| Composition comprising bortezomib Grant 10,314,880 - Kanteepan , et al. | 2019-06-11 |
| A Novel Pharmaceutical Composition Of A Lipid Lowering Compound App 20190142741 - MEHTA; Sandip P. ; et al. | 2019-05-16 |
| Oral Solution Of Ace Inhibitors App 20180325813 - Mandal; Jayanta Kumar ; et al. | 2018-11-15 |
| Oral Solution Of Dihydropyridine Derivatives App 20180303811 - Mandal; Jayanta Kumar ; et al. | 2018-10-25 |
| Pharmaceutical Composition Of Teriflunomide App 20180147148 - SATPATHY; Tarun Kumar ; et al. | 2018-05-31 |
| Pharmaceutical Composition Of Pemetrexed App 20170340639 - Mandal; Jayanta Kumar ; et al. | 2017-11-30 |
| Composition Comprising Bortezomib App 20170035831 - Kanteepan; P. ; et al. | 2017-02-09 |
| Pharmaceutically Acceptable Dosage Form Comprising Release Of Multiple Drugs From Single Oral Dosage Form App 20150328165 - MANDAL; Jayanta Kumar ; et al. | 2015-11-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 